Clinical Trials · NCT01171690

Teriparatide for Postsurgical Hypoparathyroidism

TerminatedPhase 2Teriparatide (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
Mayo Clinic
Enrollment
5
Start date
Nov 2010
Locations
1 site, United States
Primary endpoint
Hospital Length of Stay
View Teriparatide compound reference